Clinical TrialsSearch results
Number of results: 316
Other
- Phase III Randomized Study of Imatinib therapy in chornic phase chronic myeloid leukemia comparing standard dose-escalation with progressive dose-escalation (JALSG CML207study)
- Previously untreated Chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2007-09-15
Other
- Phase III Randomized Study of Induction Therapy Comparing Daunorubicin With Idarubicin Followed By Consolidation Therapy Comparing High-Dose Cytarabine With Sequential Multiagent Chemotherapy in Patients With Previously Untreated De Novo Acute Myeloid Leukemia (JALSG AML201 Study)
- Acute Myeloid Leukemia
- Japan Adult Leukemia Study Group
- 2005-09-12
Other
- Phase III study comparing FK506 with Cyclosporine A for prophylaxis of acute graft-versus-host disease after HLA-A, B and DRB1 genotypically matched unrelated bone marrow transplantation (C-SHOT 0404)
- Acute leukemia, Chronic myeloid leukemia
- Health and Labour Sciences Research Grants,Research on Human Genome,Tissue Engineering,Ministry of Health,Labour and Welfare
- 2005-09-12
Other
- Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma
- Previously treated lung adeno carcinoma
- West Japan Oncology Group
- 2009-06-19
Other
- Phase III study of Z-100 in uterine cervix cancer patients
- primary uterine cervix cancer
- ZERIA Pharmaceutical Co.,Ltd.
- 2005-09-13
Other
- Phase III trial of doxorubicin / cyclophosphamide (AC), docetaxel (D), and alternating AC and D (AC-D) as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)
- Patients with Metatatic Breast Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-12
Recruiting
- Phase III, Open-label, Study of First-line Dato-DXd in Combination WithRilvegostomig for Advanced Non-squamous NSCLC With High PD-L1Expression (TC>=50%) and Without Actionable Genomic Alterations
- Non-Small Cell Lung Cancer
- Hibi Kazushige
- 2024-05-20
Recruiting
- Phase two clinical trial of limited stage lymphoblastic lymphoma.
- Limited stage lymphoblastic lymphoma
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26
Other
- PhaseII trial of erlotinib for elderly patients with advanced or recurrent non-small cell lung cancer
- Non-small cell lung cancer
- Keio University School of Medicine Division of Pulmonary Medicine
- 2009-04-11
Completed
- PIANO study
- multiple myeloma
- Kanda Yoshinobu
- 2019-03-18